European CHMP recommends approval of paediatric license extension for bedaquiline (Sirturo)

In addition to a new 20 mg tablet, the intended license extension is for use as part of an appropriate combination regimen for pulmonary multidrug‑resistant tuberculosis in paediatric patients (5 to < 18 years and weighing at least 15 kg).

Source:

European Medicines Agency